MX2022000373A - Combinacion de ibuprofeno y tramadol para aliviar el dolor. - Google Patents

Combinacion de ibuprofeno y tramadol para aliviar el dolor.

Info

Publication number
MX2022000373A
MX2022000373A MX2022000373A MX2022000373A MX2022000373A MX 2022000373 A MX2022000373 A MX 2022000373A MX 2022000373 A MX2022000373 A MX 2022000373A MX 2022000373 A MX2022000373 A MX 2022000373A MX 2022000373 A MX2022000373 A MX 2022000373A
Authority
MX
Mexico
Prior art keywords
tramadol
combination
ibuprofen
relieve pain
pain
Prior art date
Application number
MX2022000373A
Other languages
English (en)
Spanish (es)
Inventor
Calvo Antonia Gómez
Menéndez Nuria Sanz
De La Torre Marta Vicario
Alonso Fernando García
Pérez Antonio Portolés
Serna Luis Narciso Santé
Butrón María Del Rosario Salas
Castrillón Emilio Vargas
Pérez Carlos Calandria
Córdoba Raquel Horcajada
Ruiz Ángel José Muñoz
García Jose Angel Sánchez
Gonzalez Ester Duart
Original Assignee
Farmalider Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmalider Sa filed Critical Farmalider Sa
Publication of MX2022000373A publication Critical patent/MX2022000373A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
MX2022000373A 2019-07-09 2020-07-08 Combinacion de ibuprofeno y tramadol para aliviar el dolor. MX2022000373A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19382583 2019-07-09
PCT/EP2020/069306 WO2021005129A1 (en) 2019-07-09 2020-07-08 Combination of ibuprofen and tramadol for relieving pain

Publications (1)

Publication Number Publication Date
MX2022000373A true MX2022000373A (es) 2022-02-10

Family

ID=67480112

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022000373A MX2022000373A (es) 2019-07-09 2020-07-08 Combinacion de ibuprofeno y tramadol para aliviar el dolor.

Country Status (21)

Country Link
US (1) US20220249414A1 (enExample)
EP (1) EP3996699B1 (enExample)
JP (1) JP7656339B2 (enExample)
CN (1) CN114080221B (enExample)
AU (1) AU2020309160B2 (enExample)
BR (1) BR112022000242A2 (enExample)
CA (1) CA3145632C (enExample)
DK (1) DK3996699T3 (enExample)
ES (1) ES2952013T3 (enExample)
FI (1) FI3996699T3 (enExample)
HR (1) HRP20230677T1 (enExample)
HU (1) HUE062529T2 (enExample)
MA (1) MA56341B1 (enExample)
MD (1) MD3996699T2 (enExample)
MX (1) MX2022000373A (enExample)
MY (1) MY207573A (enExample)
PL (1) PL3996699T3 (enExample)
PT (1) PT3996699T (enExample)
RS (1) RS64500B1 (enExample)
SI (1) SI3996699T1 (enExample)
WO (1) WO2021005129A1 (enExample)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB971700A (en) 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
US3652589A (en) 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
GB1497044A (en) 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
AU661723B2 (en) * 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
US5516803A (en) * 1991-10-30 1996-05-14 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
US20070117826A1 (en) * 2005-11-23 2007-05-24 Forest Laboratories, Inc. Pharmaceutical formulations comprising ibuprofen, oxycodone, and 14-hydroxycodeinone
EP2149546A1 (en) * 2008-07-31 2010-02-03 Laboratorios Del. Dr. Esteve, S.A. Salts of tramadol and ibuprofen and their crystal form in the treatment of pain
ES2356762B1 (es) * 2009-09-04 2011-11-24 Farmalider S.A. Composicion farmaceutica de ibuprofeno, tramadol y un aminoacido basico, procedimiento para su preparacion y utilizacion de la misma.
ES2423866B1 (es) 2012-02-22 2014-06-10 Farmalider, S.A. Composición farmaceútica de ibuprofeno y tramadol para inyección
ES2540151B1 (es) * 2013-10-11 2016-02-29 Farmalider S.A. Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico
GB2541571A (en) * 2014-04-10 2017-02-22 Charleston Laboratories Inc Pharmaceutical compositions

Also Published As

Publication number Publication date
BR112022000242A2 (pt) 2022-05-31
MA56341B1 (fr) 2023-07-31
SI3996699T1 (sl) 2023-10-30
JP7656339B2 (ja) 2025-04-03
ES2952013T3 (es) 2023-10-26
EP3996699A1 (en) 2022-05-18
DK3996699T3 (da) 2023-07-24
MD3996699T2 (ro) 2023-11-30
CA3145632C (en) 2024-03-12
CN114080221B (zh) 2023-12-05
EP3996699B1 (en) 2023-06-28
MY207573A (en) 2025-03-05
PL3996699T3 (pl) 2023-10-30
HUE062529T2 (hu) 2023-11-28
RS64500B1 (sr) 2023-09-29
CA3145632A1 (en) 2021-01-14
PT3996699T (pt) 2023-07-27
JP2022540854A (ja) 2022-09-20
US20220249414A1 (en) 2022-08-11
HRP20230677T1 (hr) 2023-10-13
WO2021005129A1 (en) 2021-01-14
AU2020309160A1 (en) 2022-02-17
CN114080221A (zh) 2022-02-22
AU2020309160B2 (en) 2025-06-26
FI3996699T3 (fi) 2023-08-01

Similar Documents

Publication Publication Date Title
JP2021066744A5 (ja) ブプロピオンおよびデキストロメトルファンを含む組成物
ES2553742T3 (es) Forma de dosificación farmacéutica que comprende 6'-fluor-(N-metil- o N,N-dimetil)-4-fenil-4',9'-dihidro-3'H-espiro[ciclohexano-1,1'-pirano[3,4,b]indol]-4-amina
PE20242299A1 (es) Composiciones agonistas de gip/glp1
MX2015017307A (es) Uso de pridopidina en dosis altas para el tratamiento de enfermedad de huntington.
NI201700101A (es) Composiciones farmacéuticas que comprenden n - (3, 5 - dimetoxifenil) - n'- (1-metiletil) - n - [3-(1-metil-1h-pirazol-4-il) quinoxalina-6-il]etano-1,2-diamina
CO2020013600A2 (es) Tratamiento de la hidradenitis supurativa mediante el uso de inhibidores de jak
CL2019003924A1 (es) Uso de pridopidina para el tratamiento de la disminución funcional. (divisional solicitud 201900485).
MX2019012884A (es) Terapia de combinacion.
AR124500A2 (es) Aumento de la biodisponibilidad de droga en terapia naltrexona
PE20142319A1 (es) Tratamiento de esclerosis multiple con combinacion de laquinimod y acetato de glatiramero
PE20150161A1 (es) Uso de laquinimod de dosis alta para el tratamiento de esclerosis multiple
BR112015029401A2 (pt) derivados pirazolo-pirrolidin-4-ona e seu uso no tratamento de doenças
AR085662A1 (es) Metodos y composiciones para tratar la hiperuricemia y trastornos metabolicos asociados con la hiperuricemia
MX2016010179A (es) Composiciones de donepezilo y métodos para tratar la enfermedad de alzheimer.
AR113906A1 (es) Régimen con cladribina para tratar formas progresivas de la esclerosis múltiple
CO6280474A2 (es) Composicion farmaceutica para el tratamiento de la eyaculacion precoz
CL2024001520A1 (es) Nueva composición farmacéutica oral y régimen de dosificación para la terapia de enfermedades pulmonares intersticiales
BR112015012497A8 (pt) combinações e composições farmacêuticas, seus usos, preparação combinada, e embalagem comercial
AR099299A1 (es) Inhibidor de la proteína de transferencia de éster de colesterilo (cetp) y composiciones farmacéuticas que comprenden dicho inhibidor para uso en el tratamiento o prevención de enfermedades cardiovasculares
MX2021003030A (es) Composiciones farmaceuticas adecuadas para suministro articular y su uso en tratamiento de dolor de articulacion.
AR075866A1 (es) Una dosis de ave5026 para el tratamiento de tromboembolismo venoso en pacientes con deterioro renal severo. uso. composicion farmaceutica.
MX2022000373A (es) Combinacion de ibuprofeno y tramadol para aliviar el dolor.
AR074246A1 (es) Derivados de 1-amino-alquilciclohexano para el tratamiento de trastornos del sueno
GT200600263A (es) Regimen de dosificacion para prasugrel
AR132497A1 (es) Combinación de obicetrapib amorfo e inhibidor de sglt2